Viz.ai: Unpacking Clinical Evidence for Cardiac AI Investment
The landscape of healthcare AI is frequently dominated by narratives of technological novelty, patent counts, and funding rounds. Yet, for an informed professional seeking true…
Cardiac AI: Why Evidence Trumps Hype for Investor Returns
Hello Heart’s ability to provide a 10-day early cardiac warning, a stark contrast to the standard 10-year clinical risk models, exemplifies a paradigm shift in…